Workflow
Vera Bradley Announces Appointment of Ivan Brockman to Its Board of Directors
Globenewswire· 2025-11-21 13:05
Core Insights - Vera Bradley, Inc. has appointed Ivan Brockman to its Board of Directors effective November 17, 2025, bringing extensive experience in strategic decision-making and investment banking [1][2]. Company Overview - Vera Bradley, based in Fort Wayne, Indiana, is a leading designer of women's handbags, luggage, travel items, fashion and home accessories, and unique gifts, known for its innovative designs and iconic patterns [5]. Leadership and Experience - Ivan Brockman has three decades of experience advising senior management teams and investors, currently serving as a Senior Advisor to PJT Partners and previously holding significant roles at Citigroup and Goldman Sachs [2][3]. - Throughout his career, Mr. Brockman has advised on over $100 billion of strategic transactions with major companies including Google, Microsoft, and Amazon [2]. Investment Activities - Mr. Brockman is also an active private investor in various sectors, including technology and consumer startups, with notable early-stage investments in companies like LifeLock and FIGS [3]. Strategic Transformation - Mr. Brockman expressed enthusiasm about joining Vera Bradley during a critical period of the company's strategic transformation [4]. Business Segments - Vera Bradley operates through two reportable segments: VB Direct, which includes sales through its own stores and websites, and VB Indirect, which consists of sales to specialty retail locations and other channels [6].
Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease
Globenewswire· 2025-11-21 13:05
RICHMOND, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has accepted Sangamo’s request for a rolling submission and review of the Biologics License Application (BLA) for isaralgagene civaparvovec, or ST-920, a wholly owned investigational gene therapy for the treatment of adults with Fabry disease. This acceptance follows Sangamo’s meeting with the FDA in October 2025 to discus ...
Bridger Aerospace Announces CFO Retirement and Succession Plan; Appoints Anne Hayes as Deputy Chief Financial Officer and Ernie Freedman to Board of Directors
Globenewswire· 2025-11-21 13:04
BELGRADE, Mont., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today announced the planned retirement of Eric Gerratt, Chief Financial Officer. The Company also announced a succession plan for the CFO role, with the appointment of Director Anne Hayes as Deputy Chief Financial Officer and the appointment of Ernie Freedman as an independent director an ...
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine
Globenewswire· 2025-11-21 13:01
90-day trial will measure change in general fatigue in patients with chronic babesiosis following tafenoquine treatmentStudy will run approximately 12 months and enroll up to 100 patientsInternal estimates of the unmet medical need are between 4,400 and 190,000 cases annually, with no existing FDA-approved treatment for babesiosis WASHINGTON, Nov. 21, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on de ...
Adlai Nortye to Participate in Upcoming Investor Conferences
Globenewswire· 2025-11-21 13:00
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that members of its management team are scheduled to participate in the following investor conferences: The 8th Annual Evercore Healthcare ConferenceFormat: Fireside ChatHost: Jonathan MillerDate and Time: Tuesday, December 2, 2025; 4:15 pm ...
Bitcoin Depot Appoints Scott Buchanan as Chief Executive Officer; Founder Brandon Mintz to Continue to Serve as Executive Chairman
Globenewswire· 2025-11-21 13:00
Company Also Names Industry Veteran Elizabeth Simer as COOATLANTA, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Bitcoin Depot (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced a planned leadership transition designed to support the Company’s long-term strategy, operational scaling, and M&A objectives. Bitcoin Depot’s Board of Directors has appointed Scott Buchanan, the Company’s current President and Chief Operating Officer, as Chie ...
Esperion Partner Otsuka Launches NEXLETOL® in Japan for the Treatment of Hypercholesterolemia
Globenewswire· 2025-11-21 13:00
– Company to Receive $90 Million Total Payment – – Third Largest Global Market for Cardiovascular Prevention Represents Significant Global Growth Opportunity for NEXLETOL – ANN ARBOR, Mich., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka), the Company’s partner in Japan for the development and commercialization of NEXLETOL® (bempedoic acid) tablets, received National Health Insurance Price Listing and launched NEXLETOL for the treatment ...
Diginex signs MOU to Acquire The Remedy Project to Expand Advisory Division and Provides Updates On Other M&A Activities
Globenewswire· 2025-11-21 13:00
LONDON, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a recognized provider of Sustainability RegTech solutions, today announced that it has executed a non-binding memorandum of understanding (the “MOU”) to acquire The Remedy Project Limited (“Remedy”), a pioneering organization specializing in data-driven human rights risk assessment and worker-centered remediation protocols for global supply chains. The proposed acquisition combines Diginex’s AI-powered pla ...
SEALSQ and Quobly Announce Collaboration to Advance Secure and Scalable Quantum Technologies
Globenewswire· 2025-11-21 13:00
Geneva, Switzerland / Grenoble, France / Las Vegas, NV (USA), Nov. 21, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp. (NASDAQ: LAES), ("SEALSQ" or "Company"), a global provider of post-quantum semiconductor technologies and hardware-anchored security solutions, and Quobly, a pioneer in silicon-based quantum microelectronics, today announced a collaboration to explore the convergence of secure semiconductor architectures and scalable quantum systems. A collaboration at the intersection of large-scale quantum comp ...
Firmoo Launches Trend-Conscious Eyewear Series for 2025–2026
Globenewswire· 2025-11-21 13:00
LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Firmoo, the online glasses retailer, unveiled its latest eyewear collections, capturing the defining 2025–2026 eyewear trends through globally inspired designs that merge style and function. The global eyewear market is projected to grow from approximately US$200.46 billion in 2024 to over US$335.9 billion by 2030, reflecting rising demand for fashion-driven optical products. Against this backdrop, Firmoo’s new launch introduces six standout series — Y2K, Bow, ...